139 related articles for article (PubMed ID: 884003)
1. Comparison of the lipid-lowering effect of clofibrate, and of clofibrate plus beta-pyridylcarbinol.
Graham L; Mulcahy R; Hickey N
Atherosclerosis; 1977 Aug; 27(4):487-92. PubMed ID: 884003
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of hyperlipidaemia. A comparison of the efficacy of clofibrate and beta-pyridylcarbinol (author's transl)].
Wolfram G; Keller C; Kilani S; Zöllner N
Dtsch Med Wochenschr; 1976 Jan; 101(3):76-81. PubMed ID: 1245160
[TBL] [Abstract][Full Text] [Related]
3. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
Mordasini R; Müller A; Klose G; Middelhoff G; Augustin J; Haase W; Greten H
MMW Munch Med Wochenschr; 1978 Apr; 120(15):525-8. PubMed ID: 206826
[TBL] [Abstract][Full Text] [Related]
4. A comparative trial of clofibrate and nicotinyl alcohol tartrate in hyperlipoproteinemic patients.
Dujovne CA; Azarnoff DL; Pentikainen P; Manion CV; Hurwitz A
Am J Med Sci; 1979; 277(3):255-61. PubMed ID: 222145
[TBL] [Abstract][Full Text] [Related]
5. [Clinical testing of a combination of clofibrate and beta-pyridylcarbinol in an unusual dosis relation].
Mann S; Maisenbacher HJ
Z Allgemeinmed; 1975 Aug; 51(24):1066-71. PubMed ID: 1101545
[No Abstract] [Full Text] [Related]
6. [The treatment of hypertriglyceridemia].
Wollenweber J
ZFA (Stuttgart); 1978 Feb; 54(6):349-53. PubMed ID: 636529
[No Abstract] [Full Text] [Related]
7. [Liapten--a new lipid depressor. Clinical experience in lipid metabolism disorders].
Fodor GP
ZFA (Stuttgart); 1978 Jan; 54(1):49-55. PubMed ID: 622856
[No Abstract] [Full Text] [Related]
8. [Treatment of hypercholesterolemia with beta-pyridylcarbinol. Experiences after long term treatment over 8 years (author's transl)].
Zöllner N; Keller C; Wolfram G
Med Klin; 1976 Apr; 71(18):768-74. PubMed ID: 818496
[TBL] [Abstract][Full Text] [Related]
9. Influence of nicotinic acid, niceritrol and beta-pyridylcarbinol on experimental hyperlipidemia and atherosclerosis in mini-pigs.
Lundholm L; Jacobsson L; Brattsand R; Magnusson O
Atherosclerosis; 1978 Feb; 29(2):217-39. PubMed ID: 646851
[No Abstract] [Full Text] [Related]
10. [Combination or monotherapy of hyperlipoproteinemia typus IIb, IV, V with clofibrate and m-inositolnicotinate or clofibrinic acid (author's transl)].
Schwartzkopff W; Zschiedrich M
Med Klin; 1978 Feb; 73(7):231-9. PubMed ID: 203832
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of primary hyperlipoproteinemia type IIb and IV. Comparison of the lipid lowering effect of phenformin, clofibrate, and a combination of both (author's transl)].
Koschinsky T; Lenhard P; Gries FA; Vogelberg KH; Wolfram G; Lang PD; Vollmar J
Med Klin; 1977 Sep; 72(38):1537-43. PubMed ID: 904549
[TBL] [Abstract][Full Text] [Related]
12. [Treatment with high-dose beta-pyridylcarbinol: results in patients with hypercholesterinemia].
Mordasini R; Schlumpf E; Nobile PC; Brun del Re G; Riva G
Schweiz Med Wochenschr; 1978 Apr; 108(14):533-8. PubMed ID: 635510
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia].
Arntz HR; Klemens UH; Vollmar LJ; Lang PD
Med Klin; 1978 Dec; 73(49):1731-7. PubMed ID: 723760
[TBL] [Abstract][Full Text] [Related]
14. Halofenate in the treatment of type II hyperlipoproteinemia. Double blind comparison with clofibrate.
Rees ED; Hamilton RD; Kanner IF; Wasson S; Hearn T
Atherosclerosis; 1976 Sep; 24(3):537-46. PubMed ID: 788722
[TBL] [Abstract][Full Text] [Related]
15. [Etofibrate and clofibrate in a double-blind trial on patients with raised serum-lipid levels (author's transl)].
Kaffarnik H; Schneider J; Haase W
Dtsch Med Wochenschr; 1975 Nov; 100(48):2486-8. PubMed ID: 1104303
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)].
Koschinsky T; Gries FA; Schwandt P; Weisweiler P; Hansen W; Nijssen J; Beckmann R
MMW Munch Med Wochenschr; 1977 May; 119(20):701-4. PubMed ID: 195201
[TBL] [Abstract][Full Text] [Related]
17. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
Stein EA; Heimann KW
S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
[TBL] [Abstract][Full Text] [Related]
18. Differential drug therapy of the hyperlipoproteinaemias. The efficacy of lipid lowering drugs alone and in combination.
Hansen PF
Postgrad Med J; 1975; 51(8):suppl 63-5. PubMed ID: 1052927
[TBL] [Abstract][Full Text] [Related]
19. [Combination of clofibrate and phenformin in the treatment of endogenous hypertriglyceridaemia (author's transl)].
Vogelberg KH
Dtsch Med Wochenschr; 1976 Dec; 101(51):1868-71. PubMed ID: 1001205
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate].
Gaertner U; Johannes KJ
MMW Munch Med Wochenschr; 1976 Sep; 118(36):1127-30. PubMed ID: 184377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
